Navigation Links
U.S. Genomics Awarded $9.1 Million Contract for Development of Advanced Biosensor by the U.S. Department of Homeland Security
Date:7/16/2008

WOBURN, Mass., July 16 /PRNewswire/ -- U.S. Genomics today announced the award of a $9.1 million contract by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate. The Phase IIIX contract under the Bioagent Autonomous Networked Detectors (BAND) program will enable U.S. Genomics to continue development, testing and optimization of the company's sophisticated biological sensor for the detection of airborne pathogens using single molecule DNA mapping technology.

"The award of the Phase IIIX BAND contract further validates the potential of U.S. Genomics' single molecule based DNA mapping technology for use as a biological sensor," said John J. Canepa, Chief Executive Officer of U.S. Genomics; "The resources provided under the contract will allow us to perform extensive operational testing and to advance the capabilities of our prototype systems. These prototypes currently demonstrate the capabilities of our unique, proprietary approach to rapidly detect multiple bacterial pathogens, toxins and viruses simultaneously in an environmental sample using a single reagent set. U.S. Genomics continues to be excited about working with the outstanding team at The Department of Homeland Security Science and Technology Directorate to deliver a biosensor which meets the program's mandate to improve the security of our citizens. Additionally, our DNA mapping technology can be applied to multiple sample types for use in forensic, human diagnostic and military applications.

"U.S. Genomics' unique DNA mapping technology allows extremely precise "broadband" detection of bacterial pathogens, toxins and viruses in a biological sample. The technology's readings are sensitive to the single-molecule level and yield extremely low false positive rates. Using a universal reagent set that can detect and identify pathogens, the technology produces a genetic signature unique to each DNA fragment in the sample, and also identifies the organism from which the DNA originates. Unlike other detection technologies, U.S. Genomics' detection platform does not require amplification or the use of pathogen-specific reagents for detection of each threat organism, providing broad operational flexibility and lower costs. Furthermore, U.S. Genomics' approach has the potential to identify genetically modified species, such as those that may have been deliberately engineered to elude traditional detection methods. These factors enable greater protection in defense applications and are the foundation for new, advanced diagnostics in human infectious disease.

About U.S. Genomics, Inc.

U.S. Genomics is pioneering single molecule biology technologies for biodefense and diagnostics applications by combining advances in microfluidics, optical engineering, and novel labeling strategies. Using its DNA mapping technology, the Company is developing sophisticated biological sensors for the detection and identification of pathogens and biomarkers in the air, human serum and other biologically relevant materials. The Company's biodefense focus on airborne pathogens has been funded in part by contracts from the U.S. Department of Homeland Security Science and Technology Directorate. U.S. Genomics' portfolio of products will further a greater understanding of genetics and disease that can lead to more effective therapeutics, diagnostics, and biodefense applications. For more information, please visit http://www.usgenomics.com.


'/>"/>
SOURCE U.S. Genomics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
3. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
4. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
5. WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics
6. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
7. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
8. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
9. BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
10. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
11. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" ... by its major shareholders, Clean Technology Fund I, LP ... States based venture capital funds which together ... (on a fully diluted, as converted basis), that they ... their entire equity holdings in Biorem to TUS Holdings ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... will join the faculty of the University of North Carolina Kenan-Flagler Business ... strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology:
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):